glp 1 to stop drinking alcohol GLP-1 Cravings: How Ozempic Helps Quit Why GLP-1 Medications Make You

The slowed gastric emptying characteristic of these therapies can lead to prolonged food retention, potentially affecting how flavors are perceived

Epub 2024 Jan 11

Higher-dose oral semaglutide and other developments Novo Nordisk has developed higher-dose versions of oral semaglutide (25 mg and 50 mg) to target obesity and provide stronger blood sugar and weight loss effects

The doses studied in pivotal trials represent the minimum effective doses required to demonstrate statistically significant and clinically meaningful outcomes in glycaemic control, weight reduction, and cardiovascular risk reduction

Given unequal payer coverage, the income also directly reduces GLP-1 access due to the inability to afford high co-payments or self-payment